- Home
- QNCX vs VCIG Comparison
QNCX vs VCIG Comparison
Compare QNCX & VCIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QNCX | VCIG |
|---|---|---|
| Founded | 2012 | 2013 |
| Country | United States | Malaysia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.1M | 14.2M |
| IPO Year | 2019 | 2022 |
Fundamental Metrics
Financial Performance| Metric | QNCX | VCIG |
|---|---|---|
| Price | $18.63 | $0.64 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 168.7K | 59.5K |
| Earning Date | 04-10-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.88 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.53 | ★ $1.81 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.08 | $0.20 |
| 52 Week High | $20.72 | $23.40 |
Technical Indicators
Market Signals| Indicator | QNCX | VCIG |
|---|---|---|
| Relative Strength Index (RSI) | 83.38 | 28.25 |
| Support Level | $0.68 | $0.49 |
| Resistance Level | $19.26 | $1.22 |
| Average True Range (ATR) | 1.46 | 0.33 |
| MACD | 0.03 | -0.18 |
| Stochastic Oscillator | 65.57 | 3.80 |
Price Performance
Historical ComparisonAbout QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.
About VCIG VCI Global Limited
VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology development, solutions and consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment, which focuses on listing solutions, investor relations, and boardroom strategies consultancy.